These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23144904)

  • 1. Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.
    Oomizu S; Arikawa T; Niki T; Kadowaki T; Ueno M; Nishi N; Yamauchi A; Hattori T; Masaki T; Hirashima M
    PLoS One; 2012; 7(11):e48574. PubMed ID: 23144904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.
    Oomizu S; Arikawa T; Niki T; Kadowaki T; Ueno M; Nishi N; Yamauchi A; Hirashima M
    Clin Immunol; 2012 Apr; 143(1):51-8. PubMed ID: 22341088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
    Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
    Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gal-9/Tim-3 signaling pathway activation suppresses the generation of Th17 cells and promotes the induction of Foxp3
    Wang Y; Feng T; Li H; Xiong Y; Tao Y
    Mol Immunol; 2023 Apr; 156():136-147. PubMed ID: 36921488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation.
    Edwards JP; Fujii H; Zhou AX; Creemers J; Unutmaz D; Shevach EM
    J Immunol; 2013 Jun; 190(11):5506-15. PubMed ID: 23645881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells.
    Raffin C; Raimbaud I; Valmori D; Ayyoub M
    J Immunol; 2011 Nov; 187(10):5196-202. PubMed ID: 21998454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
    Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
    Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Deubiquitinating Enzyme Ubiquitin-Specific Peptidase 11 Potentiates TGF-β Signaling in CD4
    Istomine R; Alvarez F; Almadani Y; Philip A; Piccirillo CA
    J Immunol; 2019 Nov; 203(9):2388-2400. PubMed ID: 31554694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble galectin 9 potently enhanced regulatory T-cell formation, a pathway impaired in patients with intracranial aneurysm.
    Zhao MG; Liang GB; Zhang HF; Zhao GF; Luo YH
    Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1206-1212. PubMed ID: 29978574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.
    Kared H; Fabre T; Bédard N; Bruneau J; Shoukry NH
    PLoS Pathog; 2013; 9(6):e1003422. PubMed ID: 23818845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of Gal-9 and Tim-3 crosstalk between Tregs and Th17 cells drives tobacco smoke-induced airway inflammation.
    Qiu S; Zhou G; Ke J; Zhou J; Zhang H; Jin Z; Xie W; Huang S; He Z; Qin H; Huang H; Li Q; Huang H; Tang H; Liang Y; Duan M
    Immunology; 2024 Sep; 173(1):152-171. PubMed ID: 38829009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation.
    Takeuchi H; Yokota-Nakatsuma A; Ohoka Y; Kagechika H; Kato C; Song SY; Iwata M
    J Immunol; 2013 Oct; 191(7):3725-33. PubMed ID: 23980207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1.
    Yao R; Ma YL; Liang W; Li HH; Ma ZJ; Yu X; Liao YH
    PLoS One; 2012; 7(10):e46082. PubMed ID: 23091595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells and the induction of IL-17.
    Kitani A; Xu L
    Mucosal Immunol; 2008 Nov; 1 Suppl 1():S43-6. PubMed ID: 19079228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic and additive interactions between receptor signaling networks drive the regulatory T cell versus T helper 17 cell fate choice.
    Prado DS; Cattley RT; Shipman CW; Happe C; Lee M; Boggess WC; MacDonald ML; Hawse WF
    J Biol Chem; 2021 Dec; 297(6):101330. PubMed ID: 34688667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.